These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36831595)

  • 1. Modeling Human Brain Tumors and the Microenvironment Using Induced Pluripotent Stem Cells.
    Khamis ZI; Sarker DB; Xue Y; Al-Akkary N; James VD; Zeng C; Li Y; Sang QA
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system organoids for modeling neurodegenerative diseases.
    Hou PS; Kuo HC
    IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Role of Induced Pluripotent Stem Cells and Cerebral Organoids in Treating and Modeling Neurosurgical Diseases.
    Jovanovich N; Habib A; Kodavali C; Edwards L; Amankulor N; Zinn PO
    World Neurosurg; 2021 Nov; 155():171-179. PubMed ID: 34454068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through.
    Jusop AS; Thanaskody K; Tye GJ; Dass SA; Wan Kamarul Zaman WS; Nordin F
    Front Mol Neurosci; 2023; 16():1173433. PubMed ID: 37602192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of 3D Bioprinted-Induced Pluripotent Stem Cells in Healthcare.
    Soman SS; Vijayavenkataraman S
    Int J Bioprint; 2020; 6(4):280. PubMed ID: 33088994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
    Hohmann SS; Ilieva M; Michel TM
    Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research.
    Mrza MA; He J; Wang Y
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Makes Organoids Good Models of Human Neurogenesis?
    Yang Q; Hong Y; Zhao T; Song H; Ming GL
    Front Neurosci; 2022; 16():872794. PubMed ID: 35495031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of organoid technology to brain tumors.
    Wen J; Liu F; Cheng Q; Weygant N; Liang X; Fan F; Li C; Zhang L; Liu Z
    CNS Neurosci Ther; 2023 Oct; 29(10):2725-2743. PubMed ID: 37248629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
    Hirshorn ST; Steele N; Zavros Y
    Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
    Gabriel E; Gopalakrishnan J
    J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling.
    Csöbönyeiová M; Klein M; Kuniaková M; Varga I; Danišovič Ľ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Engineering Evolves Brain Tumor Modeling.
    Koga T; Chen CC; Furnari FB
    Neurol Med Chir (Tokyo); 2020 Jul; 60(7):329-336. PubMed ID: 32536682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
    Liu C; Oikonomopoulos A; Sayed N; Wu JC
    Development; 2018 Mar; 145(5):. PubMed ID: 29519889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and Perspective.
    Bhattacharya A; Choi WWY; Muffat J; Li Y
    J Mol Biol; 2022 Feb; 434(3):167386. PubMed ID: 34883115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.